![]() Galectin Therapeutics Galectin Therapeutics uses galectin science and drug development to create new therapies for fibrotic diseases and cancer. | ![]() Signpath Pharma SignPath Pharma is a biotechnology company that develops products to treat cancer and mitigate drug-induced cardiac arrhythmia. | |||
Founding Date | Founding Date 2015 | Founding Date 2001 | Founding Date 2006 | Founding Date 2006 |
Type | Type Public | Type Public | Type Private | Type Private |
Tags | ||||
Locations | Locations South San Francisco, US HQ San Diego, US | Locations Norcross, US HQ | Locations Sandy, US HQ | Locations Salt Lake City, US HQ |
Employees | Employees 56 | Employees 717% increase | Employees 11 | Employees 13 |
Valuation ($) | Valuation ($) 2.5 b | Valuation ($) 155.1 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | ||||
Net income | Net income ($113.7m) (FY, 2025) | Net income ($30.8m) (FY, 2025) | Net income N/A | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised $ 140m | Total funding raised N/A | Total funding raised $ 5.3m | Total funding raised $ 1.7m |

Galectin Therapeutics uses galectin science and drug development to create new therapies for fibrotic diseases and cancer.
View company
SignPath Pharma is a biotechnology company that develops products to treat cancer and mitigate drug-induced cardiac arrhythmia.
View companyNavigen is a pharmaceutical discovery and development company.
View company